Company / Depreciation & Amortization
UTAH MEDICAL PRODUCTS INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$623.0K
FY2025
5-year range
$612.0K / $700.0K
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2025 after 4 years of decline, reaching $623,000.
Based on SEC 10-K filings.
$623,000 in FY2025 with a 5-year CAGR of -4.0%.
Improved from $636,000 to $623,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.0%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 1.8% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $623.0K | +1.8% |
| FY2024 | $612.0K | -3.8% |
| FY2023 | $636.0K | -2.9% |
| FY2022 | $655.0K | -6.4% |
| FY2021 | $700.0K | -8.5% |
| FY2020 | $765.0K | +15.9% |
| FY2019 | $660.0K | +8.2% |
| FY2018 | $610.0K | -1.5% |
| FY2017 | $619.0K | -2.8% |
| FY2016 | $637.0K | +4.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026